Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kellie S Rath

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Obstetrics and Gynecology|December 29, 2015
ReplyKellie S Rath, Jeffery M Fowler
American Journal of Obstetrics and Gynecology|July 31, 2015
Burnout and associated factors among members of the Society of Gynecologic OncologyKellie S Rath, Laura B Huffman, Gary S Phillips, et al.
American Journal of Obstetrics and Gynecology|May 18, 2010
Expression of soluble interleukin-6 receptor in malignant ovarian tissueKellie S Rath, Holly M Funk, Marcia C Bowling, et al.
Journal of Minimally Invasive Gynecology|June 4, 2014
Training the next generation of robotic surgeons using guided mentorship: a randomized controlled trialMargaret I Liang, Georgia A McCann, Kellie S Rath, et al.
Journal of Ovarian Research|May 14, 2013
Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogsKellie S Rath, Georgia A McCann, David E Cohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancerChelsea Bolyard, Ji Young Yoo, Pin-Yi Wang, et al.
Gynecologic Oncology|July 20, 2014
Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitorBrent J Tierney, Georgia A McCann, Shan Naidu, et al.
Gynecologic Oncology|October 8, 2013
Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality careMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Oncoscience|January 17, 2015
Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitorGeorgia A McCann, Shan Naidu, Kellie S Rath, et al.
Journal of Minimally Invasive Gynecology|January 10, 2015
Predicting inpatient stay lasting 2 midnights or longer after robotic surgery for endometrial cancerMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Obstetrics and Gynecology|December 29, 2015
ReplyKellie S Rath, Jeffery M Fowler
American Journal of Obstetrics and Gynecology|July 31, 2015
Burnout and associated factors among members of the Society of Gynecologic OncologyKellie S Rath, Laura B Huffman, Gary S Phillips, et al.
American Journal of Obstetrics and Gynecology|May 18, 2010
Expression of soluble interleukin-6 receptor in malignant ovarian tissueKellie S Rath, Holly M Funk, Marcia C Bowling, et al.
Journal of Minimally Invasive Gynecology|June 4, 2014
Training the next generation of robotic surgeons using guided mentorship: a randomized controlled trialMargaret I Liang, Georgia A McCann, Kellie S Rath, et al.
Journal of Ovarian Research|May 14, 2013
Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogsKellie S Rath, Georgia A McCann, David E Cohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancerChelsea Bolyard, Ji Young Yoo, Pin-Yi Wang, et al.
Gynecologic Oncology|July 20, 2014
Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitorBrent J Tierney, Georgia A McCann, Shan Naidu, et al.
Gynecologic Oncology|October 8, 2013
Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality careMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Oncoscience|January 17, 2015
Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitorGeorgia A McCann, Shan Naidu, Kellie S Rath, et al.
Journal of Minimally Invasive Gynecology|January 10, 2015
Predicting inpatient stay lasting 2 midnights or longer after robotic surgery for endometrial cancerMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Pageof 2